Determinants of the response to oral anticoagulant drugs in man.
D000284:Administration, Oral; D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000818:Animals; D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000925:Anticoagulants / Q000378:metabolism / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D001778:Blood Coagulation Disorders / Q000235:genetics; D001779:Blood Coagulation Factors; D002994:Clofibrate / Q000494:pharmacology; D003374:Coumarins / Q000494:pharmacology; D004231:Diuresis; D004285:Dogs; D006493:Heparin / Q000494:pharmacology; D006801:Humans; D006993:Hypnotics and Sedatives / Q000494:pharmacology; D008107:Liver Diseases; D008659:Metabolic Diseases; D010653:Phenylbutazone / Q000494:pharmacology; D051381:Rats; D012459:Salicylates / Q000494:pharmacology; D013449:Sulfonamides / Q000494:pharmacology; D013927:Thrombosis / Q000209:etiology; D014511:Uremia; D014812:Vitamin K / Q000494:pharmacology
D000305:Adrenal Cortex Hormones; D000900:Anti-Bacterial Agents; D000925:Anticoagulants; D001779:Blood Coagulation Factors; D003374:Coumarins; D006993:Hypnotics and Sedatives; D012459:Salicylates; D013449:Sulfonamides; D014812:Vitamin K; D006493:Heparin; D010653:Phenylbutazone; D002994:Clofibrate